NEW SITE — FASTER TURNAROUND, MORE LABS. READ ON
Peptide testing

Ordered Tirzepatide from Guangzhou Aoyu? Mail in a sample (US only) and let us test it.

Test my supply
+2 more ↓
60%
Finnrick rating
#274 of 281 Tirzepatide vendors
6 of 13 classifiable tests passed
natural 46% · customers 3.3★ (11)
methodology · Purity focus
Finnrick analysis · Tirzepatide

Recent evidence is weighed down by repeated identity failures and one severe fill miss: a 30 mg vial tested at 12.99 mg (-57%). Earlier high-purity passes are offset by volatile results and batch-label gaps.

methodology →
vendor intelligence report
Vendor Intelligence Report: Guangzhou Aoyu

Corporate records put the peptide storefront on a platform-only GlobalSources profile while older Aoyu listings sell unrelated goods. The report maps the identity stack, manufacturer-claim conflicts, missing credential trail, and clean-but-limited promotion sweep.

19 pages4 risk factors assessed2 Jul 2026
read the report
Peptides
#
Peptide
$/MG
Rating
N
1
Retatrutide
$0.82
73%
6
2
Tirzepatideselected
$0.40
60%
13
3
Tesamorelin
$1.45
42%
3
4
MOTS-c
-
31%
2
6
GHK-Cu
$0.10
-
0
9
PT-141
-
-
0
Contact channels
Rating trend
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%28 Apr 2026: 80%6 May 2026: 81%4 Jun 2026: 77%6 Jun 2026: 73%15 Jun 2026: 74%16 Jun 2026: 70%26 Jun 2026: 72%26 Jun 2026: 73%6 Oct 2026: 69%20 Oct 2026: 70%20 Oct 2026: 66%20 Oct 2026: 63%20 Oct 2026: 60%15 Nov 2026: current 60%80%60%Apr 26Nov 26
Showing Tirzepatide tests only
Peptide testing

Ordered Tirzepatide from Guangzhou Aoyu? Mail in a sample (US only) and let us test it.

Test my supply
Guangzhou Aoyu Tirzepatide test history
COA-backed lab tests
1-10 of 13

About Guangzhou Aoyu test results from Finnrick

Guangzhou Aoyu is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 4 peptides and 24 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible Guangzhou Aoyu peptides in this dataset are MOTS-c (2 tests), Retatrutide (6 tests) and Tesamorelin (3 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 24 recent tests.

Corrections
No corrections.
Peptide testing

Ordered Tirzepatide from Guangzhou Aoyu? Mail in a sample (US only) and let us test it.

Test my supply